New prep for colon screen uses four pills, not liquid laxative

August 31, 2012 by Alan Mozes, Healthday Reporter
New prep for colon screen uses four pills, not liquid laxative
Researchers think the easier regimen will encourage more to get 'virtual colonoscopy'

(HealthDay)—Prepping for a "virtual colonoscopy" at the Mayo Clinic now only involves swallowing four cleansing tablets, rather than the large amounts of liquid laxative typically required, researchers report.

This summer, Mayo embraced the tablet bowel prep as its standard of care for undergoing noninvasive colonography, which relies on a CT scan to generate a 3-D snapshot of the patient's colon and rectum.

The four-tablet prep, which contains the laxative agent bisacodyl, would not sufficiently prepare patients for a standard , which involves the insertion of a into the patient's for a real-time visual inspection of the region.

The screenings are recommended for people over 50 for early detection of colon cancer. The colonography route would suffice for the vast majority of patients, the Mayo team says, raising the prospect that an easier prep experience may encourage more people to undergo .

"About 70 million Americans are eligible for a screening," said Dr. C. Daniel Johnson, chair of the 's department of radiology in Arizona. "But today only about half actually do it. And one of the major obstacles has been the inconvenience of the bowel prep, which requires ingesting about a gallon of liquid the day before the procedure."

When they compared the effect of a tablet prep vs. the full bowel prep in a group of colonography patients, "we really didn't find any discernable difference between the two," he added.

Johnson and his colleagues discussed their analysis of the tablet-prep option last year in the journal Abdominal Imaging.

Colonography is an extremely accurate means of picking up polyps that are either intermediate (6 to 9 millimeters) or large (1 centimeter or more), the researchers say.

However, Dr. David Greenwald, the gastrointestinal fellowship training director at Montefiore Medical Center at the College of Medicine in New York City, pointed out that a is not as good as colonoscopy at spotting smaller polyps, which may be precancerous or cancerous already.

Greenwald, a spokesman for the American Society for Gastrointestinal Endoscopy, also said that a colonoscopy has an advantage over a colonography in that any identified polyp can be removed right then without having to undergo a secondary procedure.

"But having said that, the first goal is to identify people with polyps," he said. "So, any way we can help to get people into screening is welcome."

is really a preventable disease, he added. "Many people believe that the standard prep for these screenings is the hardest part of the procedure and keeps screening rates down, so if bisacodyl tablets can get people into colonography screenings and help to find those polyps, that's a good thing."

Johnson acknowledged, however, that a colonography isn't for everybody.

"About 2 to 5 percent of the population, those who have an inflammatory disease or an inherited disorder with multiple polyps forming at the colon, would be considered high-risk patients, and would need to undergo a colonoscopy," he explained. "And for that the tablets would leave behind fecal debris in the colon that would interfere with the procedure. So they would need a full bowel prep."

Mayo's target population for the tablet prep? "The vast majority of patients over 50 who we would say are at average or intermediate risk for colorectal cancer would be eligible for CT colonography," Johnson added.

"Of course, if we find a polyp during a colonography that patient has to then go on to have a colonoscopy," he said. "But we only find a polyp that needs to be removed about 12 percent of the time. So that means that you have an 88 percent chance of not having to go on to a colonoscopy and undertake the more burdensome prep it involves. And we think those are pretty good odds."

Explore further: Study: Virtual colonoscopy effective screening tool for adults over 65

More information: For more on colorectal cancer, visit the U.S. National Institutes of Health.


Related Stories

Study: Virtual colonoscopy effective screening tool for adults over 65

February 23, 2012
Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

Virtual colonoscopy without laxative equals standard in identifying clinically significant polyps

June 14, 2012
Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according ...

CT colonography shown to be comparable to standard colonoscopy

February 23, 2012
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...

Study answers Medicare concerns about paying for CT colonography

July 1, 2012
A new study of 1,400 Medicare-aged patients reinforces CT colonography as a screening tool for colon cancer, adding to the continued debate over Medicare coverage of the procedure.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.